Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hextar Healthcare BhdXKLS:7803 +9.09% Net-Net Working Capital is RM0.04 as of Mar. 2026. The stock has 3 warning signs investors should review. Among 588 Chemicals companies, Hextar Healthcare Bhd ranks better than 92.52% on this metric.
In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.
Hextar Healthcare Bhd's Net-Net Working Capital for the quarter that ended in Mar. 2026 was RM0.04.
The industry rank for Hextar Healthcare Bhd's Net-Net Working Capital or its related term are showing as below:
XKLS:7803's Price-to-Net-Net-Working-Capital is ranked better than 92.52% of 588
companies
in the Chemicals industry
Industry Median: 7.585
vs XKLS:7803: 1.50
Hextar Healthcare Bhd (XKLS:7803) Net-Net Working Capital Explanation
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.
Hextar Healthcare Bhd Net-Net Working Capital Related Terms
Hextar Healthcare Bhd Net-Net Working Capital Historical Data
* Premium members only.
The historical data trend for Hextar Healthcare Bhd's Net-Net Working Capital can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hextar Healthcare Bhd Net-Net Working Capital Chart
XKLS:7803 vs LIN, SHW, ECL: Net-Net Working Capital Comparison
For the Specialty Chemicals subindustry, Hextar Healthcare Bhd's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hextar Healthcare Bhd Price-to-Net-Net-Working-Capital vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Hextar Healthcare Bhd's Price-to-Net-Net-Working-Capital distribution charts can be found below:
* The bar in red indicates where Hextar Healthcare Bhd's Price-to-Net-Net-Working-Capital falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.
In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
This is a conservative way of estimating the company's value.
What does a Net-Net Working Capital of RM0.04 mean?
Hextar Healthcare Bhd (XKLS:7803) has a Net-Net Working Capital of RM0.04 as of Mar. 2026. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on Hextar Healthcare Bhd According to the industry distribution chart, Hextar Healthcare Bhd ranks #44 out of 588 companies in the Chemicals industry, placing it in the top 7.5%.
Is Hextar Healthcare Bhd's Net-Net Working Capital too high?
Hextar Healthcare Bhd's current Net-Net Working Capital is RM0.04. Based on the distribution chart, Hextar Healthcare Bhd ranks #44 out of 588 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers.
How does Hextar Healthcare Bhd's Net-Net Working Capital compare to LIN and SHW?
According to the Chemicals industry distribution chart, Hextar Healthcare Bhd ranks #44 out of 588 companies for Net-Net Working Capital. This places Hextar Healthcare Bhd in the top 8% of its industry — outperforming the majority of peers. The industry median Net-Net Working Capital is 7.59. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net-Net Working Capital for a Chemicals company?
The median Net-Net Working Capital among Chemicals companies is 7.59, based on 588 companies in the industry. Companies in the top quartile (top 25%) have a Net-Net Working Capital significantly above this median, while those in the bottom quartile fall well below. However, Net-Net Working Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net-Net Working Capital mean?
A high Net-Net Working Capital can signal that a stock is expensive relative to its fundamentals. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on Hextar Healthcare Bhd For the Chemicals industry, the median Net-Net Working Capital is 7.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hextar Healthcare Bhd's current Net-Net Working Capital is RM0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hextar Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Hextar Healthcare Bhd (XKLS:7803) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.15, compared to a current price of RM0.06 — trading 60% below its estimated fair value. The current Net-Net Working Capital is RM0.04. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net-Net Working Capital calculated?
Net-Net Working Capital is calculated from a company's financial statements. For Hextar Healthcare Bhd (XKLS:7803), the current Net-Net Working Capital is RM0.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hextar Healthcare Bhd is principally involved in investment holding. Through its subsidiaries, it manufactures and sells rubber gloves. The company offers a wide range of industrial and safety gloves, household rubber gloves, and disposable vinyl and nitrile gloves. The company operates in three segments: Gloves operation, Medical devices operation, and Investment holding. The company generates the majority of its revenue from the Gloves operation segment. It has operations in Europe, Asia, North and South America, and the Rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7803 has been successfully added to your 
